Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 4
Submit an article Journal homepage
41
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Anti-Leukemic and Anti-GVHD Effects of Campath-1H in Acute Lymphoblastic Leukemia Relapsed after Stem-Cell Transplantation

Pier Paolo Piccaluga Institute of Haematology and Medical Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, ItalyCorrespondence[email protected]
,
Giovanni Martinelli Department of Haematology, S. Salvatore Hospital, Pesaro, Italy
,
Michele Malagola Institute of Haematology and Medical Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Italy
,
Michela Rondoni Department of Haematology, S. Salvatore Hospital, Pesaro, Italy
,
Michele Bianchini Institute of Haematology and Medical Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Italy
,
Ernesto Vigna Department of Haematology, S. Salvatore Hospital, Pesaro, Italy
,
Costanza Bosi Institute of Haematology and Medical Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Italy
,
Stavroula Gaitani Department of Haematology, S. Salvatore Hospital, Pesaro, Italy
,
Giuseppe Visani Institute of Haematology and Medical Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Italy
&
Michele Baccarani Department of Haematology, S. Salvatore Hospital, Pesaro, Italy
 show all
Pages 731-733 | Received 25 Jun 2003, Published online: 03 Aug 2009

REFERENCES

  • Garcia-Manero, G. and Thomas, D. (2001) "Salvage therapy for refractory or relapsed acute lymphocytic leukemia", Hematology/ Oncology clinics of North America, 15(1), 163–205.
  • Treumann, A., Lifely, M.R., Schneider, P. and Ferguson, M.A. (1995) "Primary structure of CD52", Journal of Biological Chemistry, 270, 6088–6099.
  • Gilleece, M.H. and Dexter, T.M. (1993) "Effect of Campath-1H antibody on human hematopoietic progenitors in vitro", Blood, 82, 807 — 881.
  • Heit, W., Bunjes, D., Wiesneth, M., Schmeiser, T., Arnold, R., Hale, G. etal. (1986) "Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow trans-plantation", British Journal of Haematology, 64, 479–486.
  • Dyer, M.J., Hale, G., Hayhoe, F.G. and Waldmann, H. (1989) "Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype", Blood, 73, 1431 — 1439.
  • Rai, KR., Freter, C.E., Mercier, R.J., Cooper, M.R., Mitchell, B.S., Stadtmauer, E., et al. (2002) "Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine", Journal of Clinical Oncology, 20(18), 3891— 3897.
  • Osterborg, A., Dyer, M.J., Bunjes, D., Pangalis, G.A., Bastion, Y., Catovsky, D. and Mellstedt, H. (1997) "Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia: European study group of CAMPATH-1H treatment in chronic lymphocytic leukemia", Journal of Clinical Oncology, 15, 1567 — 1574.
  • Keating, M.J., Flinn, I., JaM, V., Binet, J.L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B. and Rai, K.R. (2002) "Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: Results of a large international study", Blood, 99, 3554 — 3561.
  • Faderl, S., Thomas, D.A., O'Brien, S., Garcia-Manero, G., Kantarjian, H.M., Giles, F.J., et al. (2003) "Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies", Blood, 101(9), 3413–3415.
  • Lundin, J., Hagberg, H., Repp, R., Cavallin-Stahl, E., Freden, S., Juliusson, G., et al. (2003) "Phase II study of alemtuzumab (anti-CD52 monoclonal antibody, Campath-1H) in patients with advanced mycosis fungoides/Sezary syndrome", Blood, 101(11), 4267 —4272.
  • Kottaridis, P.D., Milligan, D.W., Chopra, R., Chakraverty, R.K., Chakrabarti, S., Robinson, S., et al. (2000) "In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation", Blood, 96(7), 2419–2425.
  • Martino, R., Caballero, M.D., Canals, C., Simon, J.A., Solano, C., Urbano-Ispizua, A., et al. ALLOPBSCT Subcommittee of the Spanish Group for Haematopoietic Transplantation (GETH); Group GEL-TAMO (2001). "Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicenter study", British Journal of Hematology, 115, 653— 659.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.